Sign In
Buy MNK
$0.116
+0 (+0%)
At Close: Jul 20, 2022
IRIDEX Announces the Appointment of Doris Engibous to its Board of Directors
12:00pm, Tuesday, 21'st Apr 2020
IRIDEX Corporation (IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the appointment of Doris Engibous to its
Should You Buy This Biotech That Makes A Lower Risk Painkiller?
10:20am, Tuesday, 21'st Apr 2020
A company making abuse-deterrent opioids and that's barely listed in any nation-wide opioid litigation is becoming a rising star despite the prescription overdose crisis.
20,476 Shares in Mallinckrodt PLC (NYSE:MNK) Acquired by Golden State Wealth Management LLC
09:50am, Tuesday, 21'st Apr 2020
Golden State Wealth Management LLC acquired a new position in shares of Mallinckrodt PLC (NYSE:MNK) during the first quarter, according to the company in its most recent filing with the Securities & E
Mallinckrodt (NYSE:MNK) Downgraded by ValuEngine to Sell
09:42am, Monday, 20'th Apr 2020
Mallinckrodt (NYSE:MNK) was downgraded by analysts at ValuEngine from a “hold” rating to a “sell” rating in a note issued to investors on Monday, ValuEngine reports. Other equities research an
Mallinckrodt (NYSE:MNK) Shares Gap Down to $3.57
11:10am, Saturday, 18'th Apr 2020
Mallinckrodt PLC (NYSE:MNK)’s share price gapped down prior to trading on Thursday . The stock had previously closed at $3.33, but opened at $3.57. Mallinckrodt shares last traded at $3.53, with a v
Ladenburg Thalmann Financial Services Inc. Lowers Stock Holdings in Mallinckrodt PLC (NYSE:MNK)
09:11am, Saturday, 18'th Apr 2020
Ladenburg Thalmann Financial Services Inc. lowered its holdings in Mallinckrodt PLC (NYSE:MNK) by 13.5% in the fourth quarter, Holdings Channel.com reports. The firm owned 56,800 shares of the company
12 Short Squeeze Candidates To Watch
06:07pm, Friday, 17'th Apr 2020
One of the most powerful tradable market events is a short squeeze, so traders are always on the lookout for the next short squeeze candidate. S3 Partners analyst Ihor Dusaniwsky...
How ANI Pharmaceuticals Plans to Take Down a Price-Gouging Giant
02:36pm, Friday, 17'th Apr 2020
A small-cap pharmaceuticals company may hold the solution to a nearly 100,000% drug price hike.
Most Heavily Shorted Stocks - April 2020
12:38pm, Friday, 17'th Apr 2020
This article presents a list of stocks with the highest short interest as a percentage of shares outstanding. Short-sellers are having a banner year with broad-
Edison Issues Update On Silence Therapeutics (SLN)
08:50am, Friday, 17'th Apr 2020
LONDON, UK / ACCESSWIRE / April 17, 2020 / The year 2019 marked a major turnaround for Silence (LSE:SLN), as it both ramped up its development activity, with the advancement of SLN124 for iron overloa
ROCKVILLE, MD / ACCESSWIRE / April 16, 2020 / In its third week of providing emergency grants to low-income dialysis and post-transplant patients struggling to afford renal-friendly food, transportati
Mallinckrodt to Report Earnings Results for First Quarter 2020
10:45am, Thursday, 16'th Apr 2020
Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, announced today that it will report first quarter 2020 earnings results for the period ended March 27, 2020 on Tuesday, May 5, 2020.
Mallinckrodt to Report Earnings Results for First Quarter —…—…
12:00am, Thursday, 16'th Apr 2020RemeGen candidate Fast Track'd for lupus
03:13pm, Wednesday, 15'th Apr 2020
The FDA has signed off on Fast Track status for Yantai, China-based RemeGen's lead drug RC18 for the treatment of systemic lupus erythematosus (SLE).RC18 (telitacicept) is a recombinant TACI-F
